Clinical Trials Logo

Gambling clinical trials

View clinical trials related to Gambling.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT03464838 Enrolling by invitation - Clinical trials for Pathological Gambling

Effects of Transcranial Direct Current Stimulation (tDCS) in Gambling Disorder

Start date: March 6, 2019
Phase: N/A
Study type: Interventional

Gambling disorder is associated to high impulsivity and excessive risk-taking behaviour. These behavioural characteristics related to addiction are linked to cognitive processes in specific brain areas located in the prefrontal cortex (PFC). With the aim of studying the role of PFC in gambling disorder, the investigators employ transcranial current direct stimulation (tDCS), a noninvasive brain stimulation technique that applies a very weak electrical current to the superficial areas of the brain. The clinical phase of the research consists on studying the effects of tDCS in combination with cognitive behavioural therapy (CBT) in patients that attend the United Kingdom (UK) National Problem Gambling Clinic. The main objective of the project is to investigate whether the combination of tDCS and CBT can help to decrease impulsivity and risk-taking behaviour and therefore improve the treatment for gambling disorder.

NCT ID: NCT03430180 Enrolling by invitation - Clinical trials for Pathological Gambling

Effects of Intranasal Naloxone on Gambling Urges and Craving in Gambling Disorder

NalGamb
Start date: February 22, 2018
Phase: Phase 2
Study type: Interventional

Primary objective: *To determine whether treatment with naloxone hydrochloride nasal spray reduces gambling urge symptoms in patients with gambling disorder The secondary objectives of the study are: - To determine the effects of naloxone hydrochloride nasal spray on gambling severity, frequency and time, internet use, self-efficacy, quality of life, alcohol consumption, depression - To evaluate the safety of naloxone hydrochloride nasal spray in the treatment of gambling disorder